Zaman, S., Shentu, S., Yang, J., He, J., Orlowski, R. Z., Stellrecht, C. M., & Gandhi, V. (2015). Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()(). Neoplasia.

Zaman, Shadia, Shujun Shentu, Jing Yang, Jin He, Robert Z. Orlowski, Christine M. Stellrecht, and Varsha Gandhi. "Targeting the Pro-Survival Protein MET With Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()." Neoplasia 2015.

Zaman, Shadia, et al. "Targeting the Pro-Survival Protein MET With Tivantinib (ARQ 197) Inhibits Growth of Multiple Myeloma Cells()()." Neoplasia 2015.